Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

MERCK & CO., INC.

(MRK)
  Report
Delayed Nyse  -  04:03 2022-12-05 pm EST
110.01 USD   -0.03%
12/02Merck Could Retain Keytruda Patent With New Formulation
MT
12/02Compass Therapeutics, Inc. - a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases
AQ
12/01Sector Update: Healthcare Stocks Ending Slightly Higher
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Earnings Per Share (EPS): Change in analysts' estimates
Turnover: Change in analysts' estimates
EPS consensus revisions
Next year EPS consensus revisions
Revenue consensus revisions
Next year Revenue consensus revisions